CG
PETX

Cutler Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Cutler Group’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100
Closed – – 5030
2018
Q2 		$0 Hold
100
– – ﹤0.01% 5258
2018
Q1 		$0 Buy
+100
New +$446 ﹤0.01% 5690
2017
Q4 		– Sell
-251
Closed -$1K – 6465
2017
Q3 		$1K Sell
251
-357
-59% -$2.26K ﹤0.01% 5688
2017
Q2 		$4K Buy
608
+508
+508% +$3.12K ﹤0.01% 5153
2017
Q1 		$0 Buy
+100
New +$675 ﹤0.01% 7639
2016
Q4 		– Sell
-1,839
Closed -$14.9K – 7755
2016
Q3 		$17K Buy
1,839
+239
+15% +$1.99K ﹤0.01% 3624
2016
Q2 		$10K Buy
1,600
+900
+129% +$5.79K ﹤0.01% 4208
2016
Q1 		$3K Buy
+700
New +$2.63K ﹤0.01% 5403

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cutler Group's PETX Position: Q3 2018 in Review

Cutler Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2018, closing a stake of 100 shares.

Cutler Group first reported a position in PETX in Q1 2016 and held it in 8 quarters. The position peaked at $17K in Q3 2016. 100 funds tracked by Wall St. Rank hold PETX as of Q3 2018.

  • Cutler Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Cutler Group sold 100 Aratana Therapeutics, Inc. shares in Q3 2018.
  • Cutler Group first reported a position in Aratana Therapeutics, Inc. in Q1 2016 and held it in 8 quarters.
  • Cutler Group's Aratana Therapeutics, Inc. position peaked at $17K in Q3 2016.
  • 100 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2018.

Based on Cutler Group's 13F filing for Q3 2018, filed 7 Nov 2018.